My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Tesla, XPeng Build Humanoid Robotics, While N...
Palantir CTO Warns AI Safety ‘Effective Altru...
Sam Altman’s AI Nightmare Splits ETF Trade: B...
Top Economist Warns Odds of a 'Serious' Fed P...
TotalEnergies Bets Over $115 Million on AI to...
AI Slowdown Talk Turns Tech’s Biggest ‘Losers...
Middle-Aged Americans Are Filing for Bankrupt...
Elon Musk Says 'Excitement’ is Guaranteed at...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    ISHARES TRUST ISHARES BIOTECHNOLOGY ETF (NASDAQ: IBB)

    Overview
    current price
    $202.00
    $202.00
    change
    0.00 | 0.00%
    0.00 | 0.00%
    Yesterday's Close
    202.00
    open
    0.00
    volume
    0.00 M
    30d. avg volume.
    1.56 M
    1 day
    0.00 - 0.00
    52 weeks
    138.79 - 217.12
    p/e
    0.00
    beta
    0.7075
    market cap
    10.31 B
    dividend yield
    0.17%
    Industry
    -
    IBB by TradingView
    News and Commentary
    Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs The biotech sector has a new catalyst beyond GLP-1 drugs. Moderna Inc ...
    Moderna Advances Ebola Vaccine Into Human Testing Moderna Inc. (MRNA
    Rising Stars, Falling Trends: July's Industry ETF Winners and Losers As July comes to an end, it's time to take a look at the best- and worst-performing industry ETFs for the month.Among the largest ETFs that represent ma...
    FDA Approves Alzheimer's Drug Slowing Cognitive Decline The Food and Drug Administration (FDA) announced accelerated approval for lecanemab which showed evidence that it was able to slow cognitive decline in people with mild impairmen...
    Here’s Why Investors Should Consider Biotech, Pharmaceutical Stocks The financial markets are not the most pleasant and calm place right now. It's facing risks in multiple areas such as geopolitics, inflation, and economic growth. There's also th...
    Biotech ETFs May Need to Prepare for More Losses Ahead Biotechnology stocks faced their worst April on record, and more pain may be ahead for biotech-focused exchange traded funds (ETF).Popular biotech-focus...
    Biotechs Setting up for a Strong 2021 From 2009 to the middle of 2015, biotechs were one of the strongest sectors in the market. Over this period, the iShares Nasdaq Biotechnology ETF
    Moderna Vaccine Update May Boost Biotech ETFs Moderna (MRNA 
    Biotechs Break Out to New Highs For the past couple of years, the biotech sector (
    Biotechs Setting Up, Fundamentals Improving The biotech sector is exhibiting remarkable strength and resilience during these turbulent market conditions. Interestingly, biotechs were actually a laggard during the last leg...
    StockTwits
    StockTwits
    Most Shared
    Dollar Tree Says Higher Fuel Prices Are Becoming a ‘Very, Very Meaningful’ Headwind
    Apple iPhone Duo Starts at $1,999 With 7.6-Inch Foldable Display: AAPL CEO John Ternus Says No More ‘Two Phones Awkwardly Stuck Together’
    AI's Half-Trillion-Dollar Borrowing Binge Is Competing With Uncle Sam for Bond Buyers
    Most Popular
    AI's Half-Trillion-Dollar Borrowing Binge Is Competing With Uncle Sam for Bond Buyers
    Fed September Hike Odds Spike to 59% After Warsh’s Hawkish Jackson Hole Speech
    Alibaba Stock Falls 7% on Profit Miss, but Analyst Stays Bullish on AI Cloud
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Microsoft
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?